VX-765

belnacasan · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VX-765, covering 2007-12-05 to 2014-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy [Phase 2]